新型直接重编程的平滑肌细胞促进血管再生作为微血管壁细胞
Cholomi Jung1,2, Ji Woong Han3, Shin-Jeong Lee2
1Department of Internal Medicine (C.J., E.J.L.), Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
使用特定因子直接将人体纤维细胞编程为收缩平滑肌细胞 (SMCs),创造了一种新的细胞疗法. 这些重编程的SMC (rSMC) 有效地修复了血管损伤,并促进了缺血四肢的血管形成.
科学领域:
- 复原医学
- 血管生物学
- 细胞治疗
背景情况:
- 细胞疗法显示出新血管化的前景, 但通常仅限于毛细血管.
- 更大,更稳定的血管需要像光滑肌肉细胞 (SMC) 或皮质细胞这样的壁细胞.
- 现有的直接重编程方法导致SMC缺乏真正的收缩功能.
研究的目的:
- 将人体皮肤纤维细胞直接重新编程为收缩性SMC (rSMC).
- 在体内研究rSMCs在血管壁细胞形成中的作用.
- 评估rSMC对缺血病的治疗效果.
主要方法:
- 人体皮肤纤维细胞使用肌肉激素和全转网膜酸进行了重新编程.
- 对重编程SMCs (rSMCs) 的表型和收缩性进行了鉴定.
- 将SMC移植到小鼠后肢缺血模型中,以评估治疗效果和血管形成.
主要成果:
- 新的培养条件有效地将纤维细胞重新编程成可收缩的rSMC.
- 移植的rSMC可改善缺血肢体的血流恢复和血管修复.
- rSMC集成到血管壁,形成更大,更稳定的微血管,并产生再生作用.
结论:
- 从纤维细胞中产生功能性SMC.
- rSMCs通过壁细胞结合和膜信号促进血管修复和新血管化.
- 这些人类rSMC为基于细胞的治疗和研究提供了新的来源.
更多相关视频
10:57Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta
Published on: September 12, 2017
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
Tissue Renewal without Stem Cells
However, failure of such a system...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
